Sort
39,280 grants matching “leukemia”
Cellular and Molecular mechanisms of ATRA inhibition of osteoblast-induced MDS development
$301,514Stavroula Kousteni · Columbia University Health Sciences · R01 · FY2025 · AR
A Software Platform for the Identification of Cell Surface Antigens Using RNA-seq Data
$301,502Martin Akerman · Envisagenics, Inc. · R43 · FY2019 · CA
Genomic and functional approaches to characterize Chr1q gains in cancer
$301,500Jason Sheltzer · Yale University · R01 · FY2024 · CA
MicroRNA"s in the Treatment of AML
$301,442Carlo M Croce · University Of Tx Md Anderson Can Ctr · P01 · FY2010 · CA
Recognition of Chromosomal DNA by Chemically Modified Oligonucleotides
$301,440David R. Corey · Ut Southwestern Medical Center · R01 · FY2009 · GM
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED) - DCC
$301,440Jeffrey P Krischer · University Of South Florida · U01 · FY2020 · HL
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED) - DCC
$301,440Jeffrey P Krischer · University Of South Florida · U01 · FY2017 · HL
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED) - DCC
$301,440Jeffrey P Krischer · University Of South Florida · U01 · FY2016 · HL
Engineering of computational receptors and gene circuits for T-cell immunotherapy
$301,399Yvonne Yu-Hsuan Chen · University Of California Los Angeles · DP5 · FY2012 · OD
Mechanisms of Leukemogenesis in Down Syndrome
$301,396John D Crispino · Northwestern University At Chicago · R01 · FY2010 · CA
Nonsense codon activation of endonuclease-mediated mRNA decay
$301,381Daniel R. Schoenberg · Ohio State University · R01 · FY2011 · GM
Nonsense codon activation of endonuclease-mediated mRNA decay
$301,381Daniel R. Schoenberg · Ohio State University · R01 · FY2012 · GM
Molecular Mechanisms for the Assembly and Regulation of the MLL1 Core Complex
$301,362Michael S. Cosgrove · Syracuse University · R01 · FY2011 · CA
Oncogene Cooperativity in Leukemia Stem Cells
$301,353Craig T. Jordan · University Of Rochester · R01 · FY2013 · CA
Mechanisms of resistance to clinically-effective FLT3 kinase inhibitors in AML
$301,352Neil P Shah · University Of California, San Francisco · R01 · FY2013 · CA
IDURONIDASE GENE TRANSFER INTO HEMATOPOIETIC CELLS
$301,352Vanderbilt University · R01 · FY2003 · DK
Molecular concepts that monitor methionine metabolism
$301,345Peter Kaiser · University Of California-Irvine · R01 · FY2018 · GM
Measuring global, loci-specific RNA degradation to interrogate RNA dysregulation in down syndrome during development
$301,324Robin Deanne Dowell-Deen · University Of Colorado · R03 · FY2020 · HD
Role of Interleukin 23 in the Pathophysiology of GVH and GVL Reactivity
$301,317William R. Drobyski · Medical College Of Wisconsin · R01 · FY2013 · DK
Second Generation Approaches to Foamy Virus (FV) Vector SCID-X1 Gene Therapy
$301,315Grant D Trobridge · Seattle Children'S Hospital · P01 · FY2016 · AI
B CELL REPERTOIRES IN CHRONIC LYMPHOCYTIC LEUKEMIA
$301,296Feinstein Institute For Medical Research · R01 · FY2003 · CA
Regulation of Lymphocyte Development by HLH Proteins
$301,289Barbara Lynne Kee · University Of Chicago · R01 · FY2010 · CA
Genomics Shared Resource
$301,284David Eric Symer · Ohio State University · P30 · FY2017 · CA
Targeting Cell Cycle Machinery For Cancer Therapy
$301,275E Premkumar Reddy · Temple Univ Of The Commonwealth · R01 · FY2006 · CA
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer
$301,271Laurie L Parker · University Of Minnesota · R01 · FY2016 · CA